Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1008318617 | 10083186 | 17 | F | 20110804 | 20150625 | 20140417 | 20150630 | EXP | CA-ROCHE-1130084 | ROCHE | 62.47 | YR | M | Y | 79.50000 | KG | 20150630 | N | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1008318617 | 10083186 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | D | B20131,B20151,B20172,B20212,B20051, | 125276 | |||||||||
| 1008318617 | 10083186 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | D | B20131,B20151,B20172,B20212,B20051, | 125276 | 600 | MG | |||||||
| 1008318617 | 10083186 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | D | B20131,B20151,B20172,B20212,B20051, | 125276 | 600 | MG | /month | ||||||
| 1008318617 | 10083186 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | D | B20131,B20151,B20172,B20212,B20051, | 125276 | 560 | MG | |||||||
| 1008318617 | 10083186 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | D | B20131,B20151,B20172,B20212,B20051, | 125276 | 600 | MG | |||||||
| 1008318617 | 10083186 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | D | B20131,B20151,B20172,B20212,B20051, | 125276 | 668.8 | MG | |||||||
| 1008318617 | 10083186 | 7 | C | METHOTREXATE | METHOTREXATE | 1 | Unknown | D | 0 | 20 | MG | /wk | |||||||
| 1008318617 | 10083186 | 8 | C | METHOTREXATE | METHOTREXATE | 1 | Unknown | D | 0 | 10 | MG | /wk | |||||||
| 1008318617 | 10083186 | 9 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | D | 0 | 200 | MG | BID | |||||||
| 1008318617 | 10083186 | 10 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | D | 0 | 1 | MG | ||||||||
| 1008318617 | 10083186 | 11 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | D | 0 | QD | |||||||||
| 1008318617 | 10083186 | 12 | C | CELEBREX | CELECOXIB | 1 | Unknown | D | 0 | 10 | MG | QD | |||||||
| 1008318617 | 10083186 | 13 | C | CELEBREX | CELECOXIB | 1 | Unknown | D | 0 | QD | |||||||||
| 1008318617 | 10083186 | 14 | C | PANTOLOC | PANTOPRAZOLE SODIUM | 1 | Unknown | D | 0 | 40 | MG | /wk | |||||||
| 1008318617 | 10083186 | 15 | C | PANTOLOC | PANTOPRAZOLE SODIUM | 1 | Unknown | D | 0 | 200 | MG | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1008318617 | 10083186 | 1 | Rheumatoid arthritis |
| 1008318617 | 10083186 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1008318617 | 10083186 | OT |
| 1008318617 | 10083186 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1008318617 | 10083186 | Abdominal pain | |
| 1008318617 | 10083186 | Arthralgia | |
| 1008318617 | 10083186 | Arthropathy | |
| 1008318617 | 10083186 | Asthenia | |
| 1008318617 | 10083186 | Back pain | |
| 1008318617 | 10083186 | Blood pressure increased | |
| 1008318617 | 10083186 | Cataract | |
| 1008318617 | 10083186 | Eye oedema | |
| 1008318617 | 10083186 | Fall | |
| 1008318617 | 10083186 | Fungal infection | |
| 1008318617 | 10083186 | Hypertension | |
| 1008318617 | 10083186 | Infusion related reaction | |
| 1008318617 | 10083186 | Intracranial aneurysm | |
| 1008318617 | 10083186 | Ocular hyperaemia | |
| 1008318617 | 10083186 | Onychomycosis | |
| 1008318617 | 10083186 | Oxygen saturation decreased | |
| 1008318617 | 10083186 | Pain in extremity | |
| 1008318617 | 10083186 | Peripheral swelling | |
| 1008318617 | 10083186 | Weight decreased | |
| 1008318617 | 10083186 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1008318617 | 10083186 | 1 | 2005 | 201009 | 0 | |
| 1008318617 | 10083186 | 2 | 20100930 | 0 | ||
| 1008318617 | 10083186 | 3 | 20130613 | 0 | ||
| 1008318617 | 10083186 | 4 | 20150304 | 0 | ||
| 1008318617 | 10083186 | 5 | 20150527 | 0 | ||
| 1008318617 | 10083186 | 6 | 20150625 | 0 | ||
| 1008318617 | 10083186 | 7 | 2008 | 0 | ||
| 1008318617 | 10083186 | 8 | 2008 | 0 | ||
| 1008318617 | 10083186 | 10 | 2004 | 0 | ||
| 1008318617 | 10083186 | 11 | 2009 | 0 | ||
| 1008318617 | 10083186 | 12 | 2006 | 0 | ||
| 1008318617 | 10083186 | 13 | 2006 | 0 | ||
| 1008318617 | 10083186 | 14 | 2004 | 0 |